

Slim Weight Loss Clinic operates in Madison, Wisconsin, providing medical weight management services centered on GLP-1 receptor agonist therapies and hormone optimization. The clinic structures treatment around three primary peptide medications—tirzepatide, semaglutide, and liraglutide—each selected based on individual metabolic profiles, weight loss goals, and medical history. Patients undergo comprehensive metabolic assessments before initiating therapy, including fasting glucose panels, lipid profiles, thyroid function tests, and body composition analysis to establish baseline metrics and identify contraindications.
The clinic's peptide protocol begins with tirzepatide for patients requiring dual GIP/GLP-1 receptor activation, particularly those with insulin resistance or type 2 diabetes comorbidities. Semaglutide serves as the primary option for patients focused on appetite regulation and cardiovascular risk reduction, while liraglutide is prescribed for individuals requiring once-daily dosing flexibility or those transitioning from other weight management approaches. Dosing follows evidence-based titration schedules, starting at manufacturer-recommended minimums and adjusting based on tolerance, efficacy markers, and side effect profiles documented during follow-up appointments. Hormone therapy integration addresses thyroid dysfunction, testosterone deficiency in male patients, and estrogen-progesterone imbalances in women, recognizing that hormonal optimization enhances peptide therapy outcomes and addresses weight loss resistance.
The medical team includes physicians trained in obesity medicine and metabolic disorders who conduct all initial consultations and medication management appointments in person at the Madison facility. Providers review patient medication lists for potential interactions with GLP-1 therapies, assess gastrointestinal health to anticipate tolerability issues, and establish realistic weight loss timelines based on starting BMI and metabolic factors. The clinic does not offer telehealth services, requiring patients to attend scheduled visits for medication adjustments, side effect monitoring, and progress evaluations that include repeat metabolic panels and body composition measurements at 12-week intervals.
Patients receive structured nutrition guidance aligned with reduced-calorie intake patterns that complement GLP-1-induced appetite suppression, focusing on protein adequacy to preserve lean muscle mass during weight reduction phases. The clinic provides injection training for self-administration of subcutaneous peptides, covering proper needle technique, injection site rotation, and refrigeration requirements for medication stability. Follow-up schedules typically involve monthly visits during the first three months of therapy, then quarterly appointments once stable dosing is achieved and weight loss progresses predictably. Patients experiencing plateau phases undergo reassessment for metabolic adaptation, medication tolerance development, or hormonal shifts requiring protocol adjustments.
Slim Weight Loss Clinic differentiates its approach through mandatory in-person monitoring, which allows direct assessment of injection site reactions, real-time vital sign tracking during dose escalations, and immediate intervention for adverse effects such as severe nausea, pancreatitis symptoms, or gallbladder complications. The Madison location serves patients throughout Dane County and surrounding Wisconsin communities, with appointment availability structured to accommodate working professionals through extended weekday hours. The clinic maintains a focused scope limited to weight management and metabolic health rather than expanding into unrelated aesthetic or wellness services, ensuring clinical expertise remains concentrated on obesity treatment and the endocrine factors influencing body weight regulation.

Dr. Gary T. Marshall, MD, FACS
Surgeon
Dr. Gary T. Marshall practices in the New York City area and specializes in general surgery and critical care medicine.
Dr. Gary Kawesch, MD, FACS
Surgeon
Dr. Gary Kawesch practices in the Los Angeles area graduated with the highest Summa Cum Laude and Phi Beta Kappa honors from Yale University.
Dr. Thierry Jacquemin, International board-certified physician
Internal Medicine
Dr. Thierry Jacquemin has spent the last decade of his professional life helping his patients live better, smarter, longer, and prettier.
Semaglutide Weight Management
An injectable medication that mimics the GLP-1 hormone to help regulate appetite and promote weight loss.
Liraglutide Weight Management
An injectable medication that helps manage weight by regulating appetite and food intake.
Tirzepatide Weight Management
A dual GLP-1 and GIP receptor agonist that aids in weight loss by mimicking hormones involved in appetite regulation.
Metformin Weight Management
An oral medication primarily used to manage blood sugar levels, which can also aid in weight loss.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


